The IPTi Consortium consists of leading centres of malaria research in Africa, Europe and the United States, and two UN agencies — the World Health Organization and UNICEF. It has developed a comprehensive research and implementation agenda to quickly resolve scientific questions on whether intermittent preventative treatment with malaria drugs is safe and effective for infants. By answering these questions, it aims to move the intervention into policy and practice.


Related topics